Sarcoma  >>  saracatinib (AZD0530)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
saracatinib (AZD0530) / AstraZeneca
NCT00752206: A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Terminated
2
38
US
Saracatinib, Placebo
Sarcoma Alliance for Research through Collaboration, AstraZeneca
Osteosarcoma
08/17
12/17

Download Options